Consolidated Balance Sheets - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Current assets
Cash	$ 7,286,437	$ 8,958,995
Royalty receivable	49,344	99,594
Inventory, net	3,431,704	3,549,000
Prepaid and other assets	1,748,338	1,104,611
Total current assets	19,007,678	20,616,509
Long-term assets
Property and equipment, net	1,335,817	1,416,436
Right of use assets – operating leases	2,099,021	806,402
Goodwill	3,601,781	3,601,781
Intangible assets, net	30,838,779	31,509,980
Investment in equity securities	3,084,278	3,084,278
Total long-term assets	40,959,676	40,418,877
Total assets	59,967,354	61,035,386
Current liabilities
Accrued royalties and expenses	2,031,701	2,144,475
Accrued bonuses and commissions	5,808,959	7,758,284
Earnout liabilities – current	686,406	1,162,880
Operating lease liabilities – current	253,381	313,933
Total current liabilities	10,601,797	12,806,309
Long-term liabilities
Earnout liabilities – long-term	6,027,598	6,003,811
Operating lease liabilities – long-term	1,859,189	505,291
Total long-term liabilities	7,886,787	6,509,102
Total liabilities	18,488,584	19,315,411
Commitments and contingencies (Note 8)
Shareholders’ equity
Common Stock: $0.001 par value, 20,000,000 shares authorized; 8,385,027 issued and outstanding as of March 31, 2023 and 8,299,957 issued and outstanding as of December 31, 2022	8,385	8,300
Additional paid-in capital	66,529,380	65,213,987
Accumulated deficit	(24,913,011)	(23,394,757)
Total Sanara MedTech shareholders’ equity	41,624,754	41,827,530
Equity attributable to noncontrolling interest	(145,984)	(107,555)
Total shareholders’ equity	41,478,770	41,719,975
Total liabilities and shareholders’ equity	59,967,354	61,035,386
Nonrelated Party [Member]
Current assets
Accounts receivable – related party	6,467,909	6,805,761
Current liabilities
Accounts payable – related parties	1,798,061	1,392,701
Related Party [Member]
Current assets
Accounts receivable – related party	23,946	98,548
Current liabilities
Accounts payable – related parties	$ 23,289	$ 34,036